Exemestane and Rapamycin Interaction

Monitor
Mechanism-based 55% confidence

Exemestane and Rapamycin have an interaction requiring monitoring for interaction with 55% confidence. Both Exemestane and Rapamycin negatively affect lipid profiles. Combined use may significantly worsen HDL/LDL ratios. Include lipid support and get bloodwork mid-cycle. These compounds primarily affect different organ systems.

Compound Profiles

Exemestane

Steroidal Aromatase Inhibitor | Irreversible Estrogen Control

Exemestane functions as a mechanism-based (suicide) inhibitor of aromatase (cytochrome P450 19A1). Due to its steroidal structure, exemestane is recognized by aromatase as a substrate analogue and enters the enzyme's active site.

Half-life: ~24 hours Typical dose: 12.5mg EOD or 25mg E3D (estrogen management) pct, anabolic
androgen receptoraromatase androgenicaromatase inhibitorestrogenichepatotoxic
View full profile

Rapamycin

mTOR Inhibitor | Longevity & Immunosuppression

Rapamycin exerts its effects by binding to the intracellular protein FKBP12, forming a complex that directly and specifically inhibits mechanistic target of rapamycin complex 1 (mTORC1). mTORC1 is a master nutrient-sensing kinase that integrates signals from growth factors, amino acids, energy status, and stress to regulate cell growth, proliferation, and metabolism.

Half-life: ~62 hours Typical dose: 3-6 mg once weekly (longevity protocol) longevity, immune
mtor immunosuppressiveinsulin disruptinglipid disruptingteratogenic
View full profile

Combined Organ Load

Gonads
moderate
Liver
moderate
Heart
low
Pituitary
low

Shared Safety Flags

2x 2 compounds disrupt lipids (Exemestane, Rapamycin). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Exemestane, Rapamycin). Monitor accordingly.

Frequently Asked Questions

Can I take Exemestane with Rapamycin?

Yes, but with caution. Both Exemestane and Rapamycin negatively affect lipid profiles. Combined use may significantly worsen HDL/LDL ratios. Include lipid support and get bloodwork mid-cycle. Regular monitoring is advised.

Is Exemestane and Rapamycin safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: lipid disrupting, teratogenic. Monitor accordingly.

What are the interactions between Exemestane and Rapamycin?

Both Exemestane and Rapamycin negatively affect lipid profiles. Combined use may significantly worsen HDL/LDL ratios. Include lipid support and get bloodwork mid-cycle. This assessment has 55% confidence and is inferred from pharmacological mechanism analysis.

How should I time Exemestane and Rapamycin?

Exemestane has a half-life of ~24 hours and Rapamycin has a half-life of ~62 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Exemestane vs Rapamycin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.